"Five people, including two former GlaxoSmithKline researchers, were charged with a scheme to steal trade secrets from the British drugmaker for potential sale in China, according to indictments announced by the U.S. Attorney's Office in Philadelphia on Wednesday. The indictments include charges of conspiracy to steal trade secrets, conspiracy to commit wire fraud, conspiracy to commit money laundering, theft of trade secrets, and wire fraud... The alleged conspirators established three corporations in China, all using the name Renopharma, to sell the stolen information that could be used to reproduce Glaxo products and drugs in development, to competitors in China, according to the complaint."
Sunday, January 31, 2016
Five Charged in U.S. With Stealing Secrets From GlaxoSmithKline; Reuters via New York Times, 1/20/16
Reuters via New York Times; Five Charged in U.S. With Stealing Secrets From GlaxoSmithKline: